Skip to main content
Wael Saber, MD, Oncology, Milwaukee, WI, Froedtert and the Medical College of Wisconsin Froedtert Hospital

WaelS.SaberMDMS

Oncology • Milwaukee, WI

Hematologic Oncology

Associate Professor, Hematology, Medical College of Wisconsin

Join to view full profile

Dr. Saber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Saber's full profile

Already have an account?

  • Office

    9200 W Wisconsin Ave
    Division Of Neoplastic Diseases
    Milwaukee, WI 53226
    Phone+1 414-805-6800
    Fax+1 414-805-6805
  • Is this information wrong?

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 1998 - 2001
  • Ain Shams University Faculty of Medicine
    Ain Shams University Faculty of MedicineClass of 1995

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2006 - 2025
  • OH State Medical License
    OH State Medical License 2000 - 2010
  • American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disea...
    Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Flurabine Improves Transplant Outcomes in Older MDS Patients
    Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS Study
    Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplan... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Ch... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Center for International Blood & Marrow Transplant Research Celebrates 50 Years
    Center for International Blood & Marrow Transplant Research Celebrates 50 YearsApril 22nd, 2022
  • Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study Finds
    Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 9th, 2017
  • Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study Finds
    Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 8th, 2017
  • Join now to see all

Hospital Affiliations

Dr. Wael Saber, Dr. Wael Saber, MD, Dr. W Saber, Dr. Wael S. Saber